Please login to the form below

Not currently logged in

Functional genomics

This page shows the latest Functional genomics news and features for those working in and with pharma, biotech and healthcare.

GSK, Vir halt enrolment of phase 3 COVID-19 antibody study

GSK, Vir halt enrolment of phase 3 COVID-19 antibody study

The collaboration combines Vir Biotech’s monoclonal antibody platform technology with GSK’s expertise in functional genomics and capabilities in CRISPR screening to identify anti-coronavirus compounds.

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery. ... The company has invested heavily in CRISPR and the broader functional genomics platform, and its upcoming move to Cambridge will be

  • Deal Watch October 2018

    treatments based on functional genomics discovery. platform. Strategic. collaboration. $1.75B. SQZ Biotech/. ... Gilead has paid $50m upfront to gain access to Tango’s functional genomics‐based discovery platform, for which it has options on up to

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...